Supplemental Figure 4 from Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients | Synapse
September 16, 2024
Supplemental Figure 4 from Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplemental Figure 4: Radiographic response of patients that cleared their plasma (teal) at cycle 4 versus that did not (red).